Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease.
Papadakis
Konstantinos A
KA
Rosenbloom
Barry
B
Targan
Stephan R
SR
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D003424:Crohn Disease / Q000150:complications* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007107:Immune System / Q000503:physiopathology*; D000069283:Rituximab; D013921:Thrombocytopenia / Q000209:etiology*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab